Christophe Baudouin Selected Research

Emulsions

6/2022	Ciclosporin A Cationic Emulsion 0.1% for the Management of Dry Eye Disease: Facts That Matter for Eye-Care Providers.
11/2021	Cyclosporine Anionic and Cationic Ophthalmic Emulsions in Dry Eye Disease: A Literature Review.
7/2020	Cationic Emulsion-Based Artificial Tears as a Mimic of Functional Healthy Tear Film for Restoration of Ocular Surface Homeostasis in Dry Eye Disease.
1/2019	Efficacy and safety of 0.1% ciclosporin A cationic emulsion in dry eye disease: a pooled analysis of two double-masked, randomised, vehicle-controlled phase III clinical studies.
11/2018	Persistence of Efficacy of 0.1% Cyclosporin A Cationic Emulsion in Subjects with Severe Keratitis Due to Dry Eye Disease: A Nonrandomized, Open-label Extension of the SANSIKA Study.
1/2018	Topical ocular 0.1% cyclosporine A cationic emulsion in dry eye disease patients with severe keratitis: experience through the French early-access program.
11/2017	Author's Reply to: "Concerns Over: Efficacy and Safety of 0.1% Cyclosporine a Cationic Emulsion in the Treatment of Severe Dry Eye Disease".
11/2017	One-Year Efficacy and Safety of 0.1% Cyclosporine a Cationic Emulsion in the Treatment of Severe Dry Eye Disease.
8/2017	A randomized study of the efficacy and safety of 0.1% cyclosporine A cationic emulsion in treatment of moderate to severe dry eye.
11/2016	Efficacy and safety of a cationic emulsion in the treatment of moderate to severe dry eye disease: a randomized controlled study.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Christophe Baudouin Research Topics

Disease

57	Dry Eye Syndromes (Dry Eye Syndrome) 10/2022 - 01/2002
40	Glaucoma 02/2022 - 10/2003
35	Inflammation (Inflammations) 06/2022 - 11/2002
12	Keratitis 12/2020 - 11/2002
11	Open-Angle Glaucoma (Glaucoma, Open Angle) 01/2021 - 11/2009
11	Ocular Hypertension (Glaucoma, Suspect) 01/2021 - 11/2009
9	Pain (Aches) 10/2021 - 01/2018
8	Hypersensitivity (Allergy) 10/2022 - 03/2004
8	Cataract (Cataracts) 01/2022 - 02/2014
6	Blister (Bulla) 09/2020 - 11/2005
5	Corneal Injuries 10/2021 - 07/2007
4	Infections 03/2022 - 05/2007
4	Toxic Optic Neuropathy 10/2021 - 09/2007
4	Hyperemia 01/2020 - 07/2005
3	Ulcer 01/2022 - 01/2018
3	Ganglion Cysts (Ganglion) 01/2021 - 01/2016
3	Cystinosis 01/2021 - 03/2014
3	Metaplasia 01/2017 - 07/2010
3	Photophobia (Light Sensitivity) 01/2017 - 05/2009
3	Wounds and Injuries (Trauma) 11/2012 - 03/2009
3	Uveitis 06/2008 - 10/2007
2	Edema (Dropsy) 03/2022 - 03/2009
2	Endophthalmitis (Ophthalmia) 01/2022 - 09/2020
2	Ischemic Optic Neuropathy (Anterior Ischemic Optic Neuropathy) 01/2021 - 01/2018
2	Hyperalgesia 12/2020 - 11/2020
2	Neuroinflammatory Diseases 01/2020 - 02/2016
2	Blindness (Hysterical Blindness) 01/2020 - 01/2017
2	Keratoconjunctivitis Sicca 01/2017 - 03/2004
2	Fibrosis (Cirrhosis) 09/2015 - 12/2012
2	Blepharitis 03/2015 - 01/2015
2	Meibomian Gland Dysfunction 01/2015 - 11/2013
2	Necrosis 02/2008 - 09/2007
1	Obstructive Sleep Apnea 10/2022
1	Skin Diseases (Skin Disease) 10/2022
1	Epiretinal Membrane (Epiretinal Membranes) 03/2022
1	Gliosis 03/2022

Drug/Important Bio-Agent (IBA)

28	Ophthalmic Solutions (Eye Drops)IBA 11/2020 - 11/2002
16	Cyclosporine (Ciclosporin)FDA LinkGeneric 10/2022 - 01/2002
16	Benzalkonium Compounds (Benzalkonium Chloride)FDA LinkGeneric 02/2020 - 12/2003
13	EmulsionsIBA 06/2022 - 08/2009
12	HLA-DR Antigens (HLA-DR)IBA 01/2019 - 01/2002
11	Latanoprost (Xalatan)FDA Link 02/2022 - 05/2004
10	Pharmaceutical PreparationsIBA 01/2022 - 11/2002
8	Retinaldehyde (Retinal)IBA 03/2022 - 01/2012
7	Fluorescein (Funduscein)FDA LinkGeneric 01/2020 - 11/2002
6	Lubricant Eye Drops (Artificial Tears)IBA 02/2022 - 01/2017
6	CytokinesIBA 04/2018 - 12/2004
6	Antiglaucoma AgentsIBA 03/2014 - 10/2003
5	Hyaluronic Acid (Hyaluronan)IBA 11/2020 - 06/2005
5	ChemokinesIBA 04/2018 - 01/2008
4	LipidsIBA 05/2020 - 01/2017
4	Biomarkers (Surrogate Marker)IBA 01/2020 - 08/2017
4	Interleukin-6 (Interleukin 6)IBA 01/2019 - 01/2012
4	Ammonium CompoundsIBA 01/2017 - 02/2008
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2012 - 11/2006
3	Messenger RNA (mRNA)IBA 03/2022 - 04/2016
3	Cystine (L-Cystine)IBA 01/2021 - 03/2014
3	Cysteamine (Mercaptamine)FDA Link 01/2021 - 03/2014
3	SolutionsIBA 01/2021 - 11/2016
3	HCEIBA 05/2020 - 06/2011
3	Analgesics (Analgesic Drugs)IBA 12/2019 - 01/2018
3	LubricantsIBA 07/2019 - 03/2017
3	hydroxypropyl guarIBA 01/2018 - 01/2017
3	TrehaloseIBA 01/2017 - 01/2011
3	ProstaglandinsIBA 04/2016 - 07/2005
3	Synthetic Prostaglandins (Prostaglandin Analogues)IBA 01/2015 - 07/2005
3	Timolol (Blocadren)FDA LinkGeneric 11/2009 - 05/2004
2	Fibronectins (Fibronectin)IBA 03/2022 - 02/2022
2	AntioxidantsIBA 02/2022 - 10/2018
2	Tolonium Chloride FDA Link 12/2020 - 05/2019
2	Detergents (Detergent)IBA 11/2020 - 12/2012
2	EnkephalinsIBA 02/2019 - 04/2018
2	MucinsIBA 01/2019 - 07/2008
2	AntigensIBA 01/2019 - 11/2011
2	Interleukin-8 (Interleukin 8)IBA 04/2018 - 12/2004
2	Propylene Glycol (1,2 Propanediol)FDA LinkGeneric 03/2017 - 01/2017
2	HLA Antigens (Human Leukocyte Antigens)IBA 06/2016 - 10/2007
2	Carboxymethylcellulose Sodium (Polycell)FDA Link 09/2012 - 06/2005
2	OccludinIBA 09/2011 - 06/2011
2	Mitomycin (Mitomycin-C)FDA LinkGeneric 07/2008 - 11/2005
2	EndotoxinsIBA 06/2008 - 01/2008
2	Chemokine ReceptorsIBA 01/2008 - 01/2008
2	Travoprost (Travatan)FDA Link 01/2008 - 09/2007
2	LipopolysaccharidesIBA 07/2007 - 11/2006
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 06/2022

Therapy/Procedure

13	Therapeutics 06/2022 - 11/2009
9	Filtering Surgery 09/2021 - 11/2002
5	Contact Lenses 10/2022 - 10/2005
5	Slit Lamp 01/2022 - 12/2007
5	Trabeculectomy (Trabeculoplasty) 01/2019 - 11/2005
4	Phacoemulsification 01/2022 - 03/2009
4	Stents 09/2020 - 02/2014
3	Refractive Surgical Procedures 04/2015 - 10/2005
2	Operative Surgical Procedures 09/2021 - 08/2021
2	Semiconductor Lasers 09/2021 - 01/2021
2	Retreatment 08/2021 - 01/2021
2	Lasers (Laser) 08/2021 - 01/2021
2	Activities of Daily Living (ADL) 10/2020 - 11/2018
2	Drug Therapy (Chemotherapy) 05/2019 - 11/2002
2	Cautery 02/2016 - 09/2015